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Calmodulin has been labeled with rhodamine isothiocyanate (GM-RITC) and used as a 
probe for the location of calmodulin in vivo. CaM-RITC retains its capacity to regulate the 
activity of brain phosphodiesterase in a Ca 2+-dependent manner in vitro, indicating that 
the labeled protein is still active. After injection into living mammalian cells CaM-RITC 
incorporates rapidly into the mitotic spindle; the details of its localization there mimic 
closely the distribution of calmodulin seen by immunofluorescence. In interphase cells the 
CaM-RITC is excluded from the nucleus, but shows no region of specific concentration 
within the cytoplasm. Neither a 2-fold increase in cellular CaM nor the injection of anti 
CaM has any observable effect on the progress of mitosis. 
Calmodulin (CaM) is a heat-stable, calcium-binding protein which has been 
found in all eukaryotic cells so far examined. The protein mediates effects of 
calcium ions on many cellular events [ 1, 2, 31. Calmodulin has been localized by 
indirect immunofluorescence to the mitotic apparatus (MA) in several types of 
mitotic cells [4, 51. In metaphase and anaphase, this localization is to the cold- 
stable, kinetochore microtubules (MTs) of fixed cells, suggesting that CaM might 
be involved in the regulation of the movement of chromosomes to the poles [6]. It 
has been proposed that calmodulin might control the effects of endogenous 
calcium on spindle microtubule stability [4-6]. Indeed experiments concerning 
the effects of Ca*’ and CaM on cold labile brain MT assembly/disassembly in 
vitro have supported this idea [7]. Further, the tau factors, one of the major 
groups of MT-associated proteins which affect the assembly of MTs in vitro, have 
more recently been identified as CaM-binding proteins [S, 91. Other laboratories 
have extended these observations concerning CaM and Ca*+ regulation of in 
vitro MT assembly by showing that cold stable MTs from brain can be made cold 
sensitive by a CaM and Ca*+-dependent process [lo]. On the other hand, as 
more components of the mitotic spindle are characterized and the involvement of 
CaM in other structural or motile systems is detailed, other possible roles for 
spindle CaM emerge. CaM has been identified as a regulator for the activity of 
myosin light chain kinase [ 11, 121, an enzyme that controls contraction of smooth 
muscle. This enzyme has recently been identified by immunocytochemistry as a 
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spindle component [13]. Given the association of CaM with proteins of the cell 
cortex [ 141, actin-binding proteins [IS] and cilia [ 16, 171 one cannot readily infer a 
role for CaM during mitosis simply from its localization. 
In an effort designed ultimately to examine the proteins associated with CaM 
during mitosis we have chosen to study the behavior of CaM in living mitotic cells 
and thereby to define the affinity of CaM for the various cellular locations which 
have been attributed to it. Hamaguchi & Iwasa [18] first demonstrated the 
feasibility of using fluorochrome-modified CaM microinjected into fertilized sea 
urchin eggs to study the in vivo behavior of the protein. However, the fluoro- 
chrome they used, N-(7-dimethylamino-4-methyl courmauryl)-maleimide 
(DACM), is restricted in its use in vivo because of the short wavelength light 
needed for excitation. In this paper we report the use of a biochemically active 
CaM-tetramethylrhodamine isothiocyanate (CaM-RITC) conjugate [ 19, 201 which 
avoids the spectral problem of DACM labeling. We have microinjected our 
fluorescent derivative into living mammalian cells, strains PtK, BS-C-1, and 3T3, 
using both micropipet and erythrocyte-mediated microinjection. We have ob- 
tained results concerning both the location of CaM-RITC in vivo and the effects 
on the behavior of living cells of changing the endogenous concentrations of 
CaM. 
MATERIALS AND METHODS 
Microinjection 
Direct needle injection was performed as described by Graessman et al. [21] using 1 mm glass 
capillaries (W-P Instrument Co) shaped with a Sutter Instrument Co. model P-77 pipet puller to form 
needles with an outside tip diameter less than 0.5 pm. The needles were loaded through their back 
ends by capillary action. They were positioned with a Leitz micromanipulator over cells grown on 
coverslips, using a 40x water immersion phase lens and a Zeiss Universal microscope to view both 
cells and needles. Injection was accomplished by applying pressure to a 50 ml syringe connected to 
the needle while simultaneously lowering the needle into the cytoplasm. Proteins were injected in a 
solution containing 140 mM K+, 100 mM glutamic acid, 40 mM citric acid, 1 mM MgC12, and 1 mM 
ethylene glycol bi&aminoethyl ether)-N, N, N’, N’-tetraacetate (EGTA) at a pH of 7.2, a buffer 
developed for tubulin injections. We have also used phosphate buffered saline (PBS) pH 7.4 and 0.125 
M sodium borate pH 8.5 with no apparent differences in the behavior of either the cells or the CaM. 
Protein concentrations varied from 0.1 to 1 mg/ml for calmodulin, and from 0.1 to 5 mg/ml for 
fluorescently labeled bovine serum albumin (BSA), ovalbumin, or cytochrome c. 
The average volume injected with this technique was determined by injecting ‘*‘I-BSA (prepared 
using lactoperoxidase [22]) into a total of 4000 PtK cells or 2000 BS-C cells, rinsing to remove 
external lz51-BSA, and counting in a liquid scintillation counter. By this method, we estimated that 
cells received an average injection of 1-2~ lo-l3 liter: 10% of the cell’s volume. 
Erythrocyte ghost-mediated microinjection was done using established procedures [23] and a CaM- 
RITC concentration of 1 mg/ml at the red blood cell loading step. Sendai virus used for the fusions 
was a generous gift of Dr M. Rechsteiner, University of Utah. Similar loadings of red blood cells with 
lz51-CaM gave loading efficiencies of 25-30%, so we estimate that the amount of CaM delivered to 
the tissue culture cells was comparable in magnitude to that achieved in the direct needle injections. 
Microscopy 
Cells were observed during and immediately after injection with the water immersion lens. To 
facilitate long-term observations with better optics, coverslips containing injected cells were inverted 
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Fig. 1. Characterization of calmodulin-rho- 
damine conjugate. (a) SDS polyacrylamide 
slab gel of CaM-RITC in 1 with Ca2+; 2, 
with EGTA; native calmodulin in 3 with 
Ca*+; 4, with EGTA. (b) Ultraviolet ab- 
sorption spectrum of native calmodulin 
used for rhodamine conjugation. (c) Activa- 
tion of calmodulin-deficient bovine brain 
phosphodiesterase (PDE) by native and 
rhodamine-conjugated calmodulin. 
on a microscope slide in PBS using coverslip fragments as spacers between the coverslip and slide, 
and then sealed with a mixture of pamfin, petroleum jelly, and lanolin (1: 1 : 1). The microscope stage 
temperature was kept at 37°C with a Sage air curtain incubator during both injection and observation. 
Photographs of injected cells were made on a Zeiss microscope using Plus X film and developed in 
Kodak HC 110 dilution B for fine-grain negatives at ASA 800. Exposure times varied from 30 set to 2 
min. Alternatively, cells were observed using a Venus DV-2 image-intensified video camera and 
recorded in time-lapse or real time with a video tape recorder. Still photographs from the moving 
video tape were made with a Nikon camera and Pan X film using %-% set exposures. 
Protein Preparation and Labeling 
Bovine serum albumin (BSA), cytochrome c, and ovalbumin (all purchased from Sigma) were 
labeled with either fluorescein isothiocyanate (FITC, from Sigma) or tetramethyl rhodamine isothio- 
cyanate (RMRITC, from Research Organ&) in pH 9 PBS, using a fluorochrome-to-protein molar 
ratio of 4 : 1. After 4 h at 4”C, unbound fluorochrome was removed by extensive dialysis. SDS gel 
electrophoresis indicated that all of the remaining fluorochrome was bound to the protein. CaM was 
iodinated following published procedures [24] using Bolton-Hunter reagent purchased from New 
England Nuclear Corp. 
Calmodulin was purified from bovine testes by the method of Dedman et al. [25] and was 
conjugated with TMRITC as described by Welsh et al. [20]. The protein used for TMRITC conjuga- 
tion was contirmed to be calmodulin by its ultraviolet absorption spectrum, its electrophoretic 
mobility in SDS polyacrylamide gels in the presence of Ca2’ or EGTA, and its ability to activate 
calmodulin-deficient bovine brain phosphodiesterase [26]. 
Heat-inactivated CaM was prepared by boiling CaM-RITC in a pH 12 solution of PBS for 1.5 min 
followed by dialysis to lower the pH to 7.0. After this treatment, the majority of the CaM retained its 
rhodamine label, and comigrated as a somewhat broader band with CaM-RITC. CaM inactivated in 
this way is unable to activate calmodulin-deficient bovine brain phosphodiesterase [27]. 
Fluorochrome to protein ratios were determined by measuring the visible light absorbed by each 
conjugate and by standard calorimetric protein estimation. Dye molarity was estimated using free dye 
extinction coefficients of 7.4~ lo4 at 495 nm for fluorescein and 2.4~ 10“ at 555 nm for rhodamine [28, 
291; protein mass was determined by the method of Bradford [30]. Typical fluorochrome : protein 
molar ratios varied from 0.23 for rhodamine-labeled BSA to 1 .O for fluorescein BSA. 
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Fig. 2. Distribution of CaM-RITC in mitotic PtK cells. (a) Prometaphase, 10 min post-injection; (6) 
anaphase, 25 min post-injection in the same cell as shown in (a), photographed on plus-X film. (c-J) 
Video time-lapse recording of the same cell during (c) metaphase; (d, e) late anaphase; v) telophase at 
2, 13, 21 and 29 min post-injection, respectively. (a, b) x 1600; (c-fl x2400. 
Cell Culture 
The rat kangaroo cell line (PtKl) African green monkey kidney cells (BS-C-I), human cells (HeLa), 
and mouse 3T3 cells were grown as previously described [31]. Large numbers of mitotic cells for use 
in the RBC-mediated microinjections were gathered by mechanically dislodging the rounded cells 5 h 
after release from a 24 h exposure to medium supplemented with 1 mM thymidine. 
Anti-Calmodulin 
Antibodies against bovine testis calmodulin were raised in sheep, using performic acid-oxidized 
CaM, essentially as described by Van Eldik & Watterson for the production of rabbit anticalmodulin 
WI. 
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RESULTS 
Characterization of CaM-RZTC 
CaM used for the synthesis of CaM-RITC showed the characteristic ultraviolet 
absorption spectrum (fig. 1 b), indicating that the protein was indeed CaM [33, 
341. SDS gel electrophoresis followed by silver staining indicated that the CaM 
was homogeneous. Calmodulin labeled with TMRITC was found to have cal- 
cium- and EGTA-dependent mobilities on SDS gels, identical to those of unmodi- 
fled CaM (fig. 1 a). Furthermore the fluorochrome-modified CaM was found to 
activate CaM-deficient bovine brain phosphodiesterase in a dose- and calcium- 
dependent manner, identical to that of unmodified protein (fig. 1 c). These tests 
indicate that the CaM-RITC should be suitable as an in vivo substitute for 
endogenous CaM. 
CaM-RZTC Microinjection into Living Cells 
When CaM-RITC was microinjected into mitotic PtK cells via the direct 
micropipette method, the fluorescent CaM conjugate was seen to diffuse rapidly 
throughout the cell cytoplasm. An accumulation of the fluorescent protein in the 
spindle could be seen within a few seconds after injection. This rapid recruitment 
of CaM-RITC into the mitotic apparatus was observed, regardless of the stage of 
mitosis at which the protein was injected. At prometaphase and metaphase, CaM- 
RITC became located predominantly near the poles of the spindle (fig. 2a). In 
early anaphase, fluorescence was confined to the space between chromosomes 
and poles (fig. 2 b). In late anaphase, the fluorescence was also concentrated in 
the interzone region. CaM injected at either 0.1 or 1 mg/ml in the needle gave 
qualitatively identical results. Once concentrated in the spindle, CaM-RITC 
persisted there through telophase, allowing the changes in localization to be 
followed in individual cells. Prolonged observations with bright 546 nm light, 
however, increased the incidence of chromosomal non-disjunction. Long-term 
observations were therefore conducted with phase contrast optics using dim 
light, interrupted with brief visualizations of the CaM-RITC by epifluorescence. 
A total of 5-7 min viewing with 546 nm light by epifluorescence had no visibly 
deleterious effects on the cells. By following one cell through time we confirmed 
that a single cell will show the multiple localizations of spindle CaM (fig. 2 c-J) as 
described for fixed mitotic cells by immunofluorescence [4-6]. 
The concentration of fluorescent protein into the mitotic apparatus was ob- 
served only with biochemically active CaM-RITC (fig. 3). CaM-RITC inactivated 
by elevated temperature at alkaline pH failed to concentrate in any portion of 
mitotic or interphase cells (fig. 3 b). Likewise, BSA-RITC, BSA-FITC, cytoch- 
rome c-RITC, and ovalbumin-RITC all distributed evenly through the cytoplasm 
of mitotic cells, with no concentration or sticking occurring in the spindle (fig. 3). 
No specific localization for CaM was seen in interphase cells, either immedi- 
ately following injection or when viewed up to 24 h after injection (fig. 4). The 
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Fig. 3. Specificity of CaM-RITC localization in metaphase F’tK cells. (a) Biochemicaily active CaM- 
RITC; (b) inactive CaM-RITC; (c) BSA-RITC; (d) cytochrome c-RITC. (a, c) X 1600; (b) X 1000. 
CaM-RITC did, however, retain its ability to be localized specifically, since cells 
entering mitosis 24 h after injection showed CaM-RITC concentrated in their 
spindles (fig. 4 c). A small fraction of the fluorescence in these cells is localized in 
small spheres, suggesting that the injected CaM is being turned over by the 
catabolic systems of the cell (fig. 4) [35]. 
CaM-RITC microinjected into living HeLa cells by fusion with loaded red 
blood cell ghosts showed a distribution of fluorescence essentially identical to 
that observed for CaM-RITC injected by needles into PtK cells, taking into 
account the differences in spindle morphology between the two cell types (fig. 5). 
We also visualized the location of CaM in vivo by needle injecting PtK cells with 
affinity-purified, sheep antiCaM at a concentration of 9.6 mg/ml in the needle 
(fig. 6). These cells were fixed for immunofluorescence 10-20 min after injection 
and stained with fluorescein-labeled rabbit anti-sheep IgG. The location of flu- 
orescence was essentially identical to that seen here with CaM-RITC and similar 
to that previously described by conventional indirect immunofluorescence with 
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Fig. 4. Localization of CaM-RITC in B-SC cells 10 min and 25 h after microinjection with CaM-RITC. 
(a) Interphase cell 10 min post-injection; (b) interphase cells; (c) anaphase cell 25 h post-injection. 
x1600. 
Fig. 5. Erythrocyte-mediated microinjection of CaM-RITC into HeLa cells. x600. 
Fig. 6. Microinjection of calmodulin antibody into a mitotic and an interphase PtK cell. Cells were 
microinjected with affinity-purified sheep anti-calmodulin, fixed in formalin 10 min after injection and 
permeabilized with cold acetone. The cells were then incubated with fluorescein conjugated rabbit 
anti-sheep IgG to localize injected antibody. In interphase, the immunoglobulin was distributed 
evenly throughout the cytoplasm but was excluded from the nucleus. During mitosis, antibodies were 
found associated with the mitotic apparatus in a pattern similar to that seen with CaM-RITC. x 1600. 
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the same antibody, except that the injected antibody showed no staining of stress 
fibers (fig. 6). 
Cells injected with excess CaM-RITC or antiCaM antibody were not notice- 
ably perturbed by the injections. 87% of mitotic cells injected with sufftcient 
antibody to bind roughly all of the endogenous CaM were found as pairs of 
daughter cells 90 min after injection (66/76 cells). In our hands, typically 85-100% 
of mitotic cells injected with BSA or other control proteins finish mitosis success- 
fully during this time period. 
DISCUSSION 
Our results provide new evidence confirming previous observations that CaM 
is specifically located in the mitotic spindle. By using CaM-RITC, we have been 
able to follow CaM localization in vivo and obviate some of the potential 
problems characteristic of immunofluorescence. There are, however, potential 
pitfalls in the method used here, and appropriate controls for these difficulties are 
essential. Pardue et al. [19] labeled CaM with RITC, showing that it could remain 
functional, but that some preparations of CaM-RITC lost their Ca+-dependent 
shift in mobility on SDS gels and their capacity to activate phosphodiesterase. It 
was therefore critical to demonstrate that the CaM-RITC used was active. The 
phosphodiesterase assay we have employed demonstrates that our modified CaM 
can both bind calcium and bind to an enzyme it is known to regulate. While one 
can never prove that a modified protein is indistinguishable from its unmodified 
form, these two significant properties of a functional CaM have been retained by 
our fluorochrome-labeled protein. 
It is also important to rule out a number of potential artefacts which could 
account for the observed localization of CaM-RITC in the spindles of injected 
cells [36, 37, 381. For example, Wang & Taylor [39] have found that in sea urchin 
blastomeres, injected proteins are often excluded from the yolk-rich cytoplasm 
and so are concentrated in the spindle region. Such behavior cannot account for 
our observations on tissue culture cells, since the injection of a variety of non- 
spindle proteins (BSA, ovalbumin, cytochrome c) results in a uniform distribu- 
tion throughout both the cytoplasm and the spindle. Further, the injected CaM- 
RITC has a fibrous appearance in the spindle (fig, 2a) rather than the diffuse 
localization seen for control proteins in sea urchin embryos [33]. Finally, the 
localization of CaM-RITC in the spindle is seen only with functional CaM; CaM 
that had been boiled at alkaline pH or rendered non-functional during the rhoda- 
mine labeling does not show spindle association (fig. 3 b). 
The mitotic localization described here corroborates the immunofluorescent 
pattern seen by others. We did not, however, see the prominent mitochondrial 
[19, 401 or stress fiber localization [31, 401 in interphase cells that has been 
observed with immunofluorescence or by binding CaM-RITC to fixed cells. Our 
observations are, however, consistent with the ultrastructural localizations of 
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CaM recently reported by Willingham et al. [41]. Several possibilities may 
explain the differences in the results from different methods. In our interphase 
cells the cytoplasm is generally bright so that a small CaM concentration differ- 
ence between particular structures and the surrounding cytoplasm might be 
obscured. The fixation protocols used in the other studies may have enhanced 
these differences in concentration by washing out “soluble” CaM. Alternatively 
the injected CaM may not readily replace endogenous CaM in mitochondria and 
stress fibers. Finally, it is possible that these localizations previously described 
are a result of some preparative modification of the cell for light microscopy 
which induces non-physiological CaM binding. 
We did not observe any anomalies in the behavior of cells which had been 
injected with sufficient CaM approximately to double the intracellular CaM 
concentration. Hamaguchi & Iwasa [18] also saw no alterations in development 
of urchin eggs which contained about 2.5 times the normal amount of CaM. 
Presumably this is because the cell is maintaining intracellular calcium concentra- 
tions at a low level, so that the addition of extra CaM simply increases the pool of 
inactive CaM in the cell. The injection of affinity-purified antibody to CaM also 
failed to affect the ability of mitotic cells to divide. It should be pointed out, 
however, that our assays would not have detected subtle changes in chromosome 
behavior or rates of movement, only a blockage or significant slowing of move- 
ment. Further, since the antibody used was not a precipitating antibody, it may 
simply have bound inocuously to a portion of the CaM molecule. Finally, while 
we injected enough antibody to bind essentially all of the cell’s CaM, some 
fraction of the CaM in vivo may be situated so as to block binding or some 
fraction of the antibody may be inactive in vivo. We cannot conclude that CaM is 
irrelevant for mitosis. 
The most striking findings of the mitotic injection studies are the rapidity with 
which CaM is concentrated in the spindle and the fact that CaM can be added to 
the spindle at any time in the mitotic cycle. Since we introduce an average of 
1.5X IO-” liter per cell, the protein concentration range injected (0.1-I mg/ml) 
means that the CaM level in the injected cells is elevated 6.5-65% (assuming 
0.15-0.27 pg CM per cell [41]). Given that the injection of 0.1 mg/ml CaM-RITC 
gave results qualitatively identical to those observed with the 1 mg/ml concentra- 
tion, the rapid recruitment of CaM to the spindle is not likely to be an artefact of 
the high concentrations of CaM injected. We cannot rule out the possibility, 
however, that even a 5-10% increase in CaM levels would affect an equilibrium 
between CaM bound in the spindle and that free in the rest of the cell. 
The CaM-RITC we have utilized has a distinct advantage over the DACM-CaM 
described by Hamaguchi & Iwasa [18]. Because the rhodamine excitation maxi- 
mum is in the green, cells are less damaged by observation than with the near UV 
excitation needed for DACM. This eliminates background fluorescence from 
cellular components and permits prolonged observation of single cells. This fact 
has allowed us to observe the transition in position of CaM which occurs at 
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anaphase and should allow one to monitor the effects of substances such as 
calcium, stelazine, or antibodies, on CaM location and function. 
Our observations suggest the possibility of experimentally exchanging endog- 
enous CaM, either in vivo or in lysed cell models, with CaM modified by cross- 
linking reagents [42]. This type of experiment may allow one to determine the 
near neighbors of CaM in the spindle and in so doing, to provide an indication of 
the molecules and processes that CaM regulates in the mitotic spindle. 
This work was supported by grants from the NIH (GM 30213 to J.R.M., and HD 15246 to M.J.W.) 
and the ACS (CD8 to J.R.M. and IN 40V to the University of Michigan and J.J.W.). The equipment 
for microinjection was purchased in part through a Biomedical Research Support Grant to the 
University of Colorado and through a gift from Colorado Video, Inc. 
REFERENCES 
1. Means, A R, Tash, J S & Chafouleas, J G, Physiol rev 62 (1982) 1. 
2. Cheung, W Y, Science 207 (1980) 19. 
3. Klee, C B, Crouch, T H & Richman, P G, Ann rev biochem 49 (1980) 489. 
4. Welsh, M J, Dedman, J R, Brinkley, B R & Means, A R, Proc natl acad sci US 75 (1978) 1867. 
5. Andersen, B, Osbom, M & Weber, K, Cytobiologie 17 (1978) 354. 
6. Welsh, M J, Dedman, J R, Brinkley, B R & Means, A R, J cell biol 81 (1979) 624. 
7. Marcum, J M, Dedman, J R, Brinkley, B R & Means, A R, Proc natl acad sci US 75 (1978) 3771. 
8. Sobue, K, Fujita, M, Muramoto, Y & Kakiuchi, S, FEBS lett 132 (1981) 137. 
9. Abe, T & Saisu, H, Biomed res 3 (1982) 207. 
10. Job, D, Fischer, E & Margolis, R L, Proc natl acad sci US 78 (1981) 4679. 
11. Yagi, K, Yazawa, M, Kakiucki, S, Ohshima, M & Uenishi, K, J biol them 253 (1978) 1338. 
12. Dabrowska, R, Sherry, J M, Aromatorio, D K & Hartshome, D J K, Biochemistry 17 (1978) 253. 
13. Guerriero, V, Rowley, D R & Means, A R, Cell 27 (1981) 449. 
14. Glenney, J, Glenney, P, Osborn, M & Weber, K, Cell 28 (1982) 843. 
15. Sobue, K, Morimoto, K, Kanda, K, Maruyama, K & Kakiuchi, S, FEBS lett 138 (1982) 289. 
16. Blum, J J, Hayes, A, Jamieson, G & Vanaman, T C, J cell biol 87 (1980) 386. 
17. Jamieson, G A , Vanaman, T C & Blum, J J, Proc natl acad sci US 76 (1979) 6471. 
18. Hamaguchi, Y & Iwasa, F, Biomed res 1 (1980) 502. 
19. Par-due, R L, Kaetzel, M A, Hahn, S H, Brinkley, B R & Dedman, J R, Cell 23 (1981) 533. 
20. Welsh, M J, Aster, J, Ireland, M, Alcala, J & Maisel, H, Science 216 (1982) 642. 
21. Graessmann, A, Graessmann, M & Mueller, C, Meth enzymo165 (1980) 816. 
22. Miyachi, Y, Vaitukaitis, J, Nieschlag, E & Lipsett, M B, J clin endocrinol metabolism 34 (1972) 
23. 
23. Schlegel, R & Rechsteiner, M, Cell 5 (1975) 371. 
24. Chafouleas, J G, Dedman, J R, Munjaal, R P & Means, A R, J biol them 254 (1979) 10262. 
25. Dedman, JR, Potter, J D, Jackson, R L, Johnson, J D & Means, A R, J biol them 252 (1977) 8415. 
26. Filbum, C R & Kam, J, Anal biochem 52 (1973) 505. 
27. Cheung, W Y, J biol them 246 (1971) 2859. 
28. Naim, R C, Fluorescent protein tracing. Churchill Livingston, Edinburgh, London and New 
York (1976). 
29. Taylor, D L, Reidler, J, Spudich, J A & Stryer, L, J cell biol 89 (1981) 362. 
30. Bradford, M, Anal biochem 72 (1976) 248. 
31. Zieve, G, Turnbull, D, Mullins, J M & McIntosh, J R, Exp cell res 126 (1980) 397. 
32. Van Eldik, L J & Watterson, D M, J biol them 256 (1981) 4205. 
33. Dedman, J R, Welsh, M J & Means, A R, J biol them 253 (1978) 7515. 
34. Klee, C, Biochemistry 16 (1977) 1017. 
35. Stacey, D W & Allfrey, V G, J cell biol 75 (1977) 807. 
36. Kreis, T & Birchmeier, W, Int rev cytol 75 (1982) 209. 
37. Wang, K, Feramisco, J R & Ash, J F, Meth enzymol 85 (1982) 514. 
Exp Cell Res 149 (1983) 
Distribution of calmodulin 385 
38. Wang, Y-L, Heirple, J M & Taylor, D L, Meth cell biol 25 (1982) 1. 
39. Wang, Y-L & Taylor, D L, J cell biol81 (1979) 672. 
40. Pardue, R L, Perry, G W, Brady, R C & Dedman, J R, J cell bio196 (1983) 1149. 
41. Willingham, M C, Wehland, J, Klee, C, Richert, N, Rutherford, A & Pastan, I, J histochem 
cytochem 31 (1983) 445. 
42. Chafouleas, J G, Pardue, R L, Brinkley, B R, Dedman, J R & Means, A R, Proc natl acad xi US 
78 (1981) 996. 
43. Andreasen, T J, Keller, C H, LaPorte, D C, Edelman, A M & Storm, D R, Proc natl acad sci US 
78 (1981) 2782. 
Received June 2, 1983 
Revised version received June 30, 1983 
Printed in Sweden 
Exp Cell Res 149 (1983) 
